BBH Holdings Information

BBH is an equity ETF with a total of 25 individual holdings. The top holdings are Amgen stock at 14.85%, Gilead Sciences at 14.62%, Vertex Pharmaceuticals at 8.33%, Regeneron Pharmaceuticals at 7.49%, and argenx SE at 5.10%.

Total Holdings

Top 10 Percentage

71.02%

Asset Class

Equity

ETF Category

Health

Assets

355.88M

PE Ratio

23.21

Breakdown by Sector

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	AMGN	Amgen Inc.	14.85%	153,582
2	GILD	Gilead Sciences, Inc.	14.62%	390,092
3	VRTX	Vertex Pharmaceuticals Incorporated	8.33%	67,053
4	REGN	Regeneron Pharmaceuticals, Inc.	7.49%	36,132
5	ARGX	argenx SE	5.10%	26,852
6	IQV	IQVIA Holdings Inc.	4.34%	93,651
7	INSM	Insmed Incorporated	4.22%	104,290
8	ALNY	Alnylam Pharmaceuticals, Inc.	4.15%	46,120
9	NTRA	Natera, Inc.	3.97%	73,931
10	BIIB	Biogen Inc.	3.95%	75,443
11	UTHR	United Therapeutics Corporation	3.48%	23,856
12	MRNA	Moderna, Inc.	3.33%	226,910
13	ONC	BeOne Medicines AG	3.08%	40,622
14	RVMD	Revolution Medicines, Inc.	2.79%	109,365
15	ILMN	Illumina, Inc.	2.56%	75,133
16	INCY	Incyte Corporation	2.24%	88,766
17	BNTX	BioNTech SE	2.16%	90,077
18	NBIX	Neurocrine Biosciences, Inc.	1.98%	54,628
19	BMRN	BioMarin Pharmaceutical Inc.	1.39%	91,597
20	TECH	Bio-Techne Corporation	1.38%	95,803
21	CRL	Charles River Laboratories International, Inc.	1.25%	27,539
22	ICLR	ICON Public Limited Company	1.21%	42,718
23	QGEN	Qiagen N.V.	1.16%	106,309
24	TEM	Tempus AI, Inc.	0.95%	76,175
25	n/a	Us Dollar	0.02%	83,152

As of Mar 27, 2026